KRISTINA LABONTE: Open Payments
NPI 1699786582 · ANSONIA, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,050 in 106 payments from 16 companies in 2025. Trend: 2023 $1,787 · 2024 $1,977 · 2025 $2,050
Food & beverage: $1,971Education: $79
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $608 |
| GlaxoSmithKline, LLC. | 36 | $436 |
| Verona Pharma, Inc. | 12 | $164 |
| Genentech USA, Inc. | 5 | $148 |
| Insmed, Inc. | 5 | $102 |
| Lilly USA, LLC | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
| Electromed, Inc. | 7 | $71 |
| Viatris Specialty LLC | 4 | $67 |
Products named: FASENRA, NUCALA, BREZTRI, TRELEGY ELLIPTA, DUPIXENT, Ohtuvayre, Xolair, Arikayce.
Industry payments across CT — which companies pay providers there.
